Form 4: Progyny COO Melissa Cummings Executes Stock Tax Withholding
Statement of Changes in Beneficial Ownership
Progyny, Inc. Chief Operating Officer Melissa Cummings reported the withholding of 4,172 shares to cover tax obligations upon the vesting of restricted stock units.
Summary
- Chief Operating Officer Melissa Cummings disposed of 4,172 shares of common stock on April 14, 2026.
- The transaction was executed at a price of $16.98 per share.
- The disposal was a mandatory withholding of shares to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
- Following this transaction, the reporting person maintains a beneficial ownership of 82,949 shares of Progyny common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative event, as the share reduction is strictly for tax compliance and does not reflect a change in executive confidence.
Positives
- The transaction reflects the vesting of equity compensation, which is a standard component of executive incentive structures.
Negatives
- The transaction represents a reduction in the direct shareholding of a key executive, though it is purely for tax compliance purposes.
Risks
- None identified; this is a routine administrative transaction related to tax withholding.
Future Outlook
No forward-looking guidance or strategic outlook provided in this filing.
Industry Context
StockSavvy.ai notes that this filing is a routine disclosure of executive equity management and does not signal a change in corporate strategy or market sentiment regarding the company's performance.
Comparison to Industry Standards
- The transaction follows standard corporate governance practices for executive compensation and tax compliance in the healthcare services sector.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a standard tax-related equity settlement.
Key Dates
| Date | Description |
|---|---|
| 04/14/2026 | Date of the stock transaction involving tax withholding. |
| 04/16/2026 | Date the Form 4 was signed and filed with the SEC. |
Keywords
Progyny, PGNY, Insider Trading, Form 4, Executive Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.